2026 B2B CPC, Lead-Action CPA, and MQL Benchmarks for Medical, Healthcare & Life Sciences

Who this report is for

This report is for medical-device, diagnostics, health-technology, laboratory, research, biotech, pharmaceutical-supply, and institutional-service organizations running B2B demand programs. It is most useful when the team can distinguish patient or clinical-information use from research, operational, and procurement intent.

Contents

The report explains metric boundaries, healthcare and life-sciences demand context, CPC and qualification drivers, the Clinical-Research-Procurement Intent Separation Grid, a reproducible scenario, comparison controls, method, limits, FAQs, sources, visuals, and implementation notes.

Benchmark snapshot

Metric 2026 value Semantic label Denominator Source role Interpretation Advertising CPC USD 6.43 per click pricing_system_ value Paid clicks Frozen pricing-system registry Traffic cost only Lead-action CPA USD 82 per captured action sellersgpt_mode led Valid configured actions SellersGPT CPA v2.1 Capture cost before role and fit review Implied click-to-action rate 7.84% derived_calcula tion Actions / paid clicks USD 6.43 / USD 82 Consistency diagnostic only Modeled lead-to-MQL rate 31.7% sellersgpt_mode led MQLs / captured actions MQL v1.0 Modeled fit-plus-en gagement yield Modeled cost per MQL USD 260 per MQL sellersgpt_mode led Acquisition cost / modeled MQLs Formula and rounding Planning value, not product charge Planning band USD 205-315 per MQL sellersgpt_mode led Scenario range Model sensitivity Not a clinical or statistical interval Confidence Medium-High sellersgpt_mode led Mapping judgment Proxy review Strong adjacent evidence, broad internal mix

What the data says

The USD 6.43 CPC is 26.1% above the USD 5.10 portfolio reference. That relative cost does not establish clinical or commercial value. Google defines CPC as click cost divided by clicks (Google Ads Help, Average CPC). The USD 82 CPA divides cost by configured actions; the action itself must be named before the metric is interpretable (Google Ads Help, Average CPA). Applying the 31.7% modeled rate gives USD 82 / 0.317 = USD 258.68, rounded to USD 260. Adobe Marketo's first-party guidance supports scoring with fit, behavior, negative signals, and an agreed handoff threshold, but does not set a healthcare MQL rate or product price (Adobe Experience League, Build Person Scoring Models).

What this benchmark measures

The three units are a paid click, a captured action, and a modeled MQL. Actions may include a demo request, product inquiry, clinical or technical resource registration, sample request, institutional consultation, or vendor form. They remain event types, not interchangeable buyers. A SellersGPT Qualified Lead follows a separate, versioned product rule. The actual unit price is null in this report and cannot be derived from benchmark metrics.

Industry demand context

Medical, healthcare, and life sciences combines healthcare providers, devices, diagnostics, digital health, laboratories, biotechnology, research services, and regulated supply. Census NAICS separates health care and social assistance from manufacturing and professional scientific services, so SGT-18 is a commercial composite (U.S. Census Bureau, NAICS). Regulatory and data roles can change evaluation. FDA explains that medical devices are classified into Classes I, II, and III, with increasing regulatory controls (FDA, Overview of Device Regulation). HHS explains that HIPAA applies to covered entities and business associates, and that certain service relationships involving protected health information require written arrangements (HHS, Covered Entities and Business Associates). These facts support role and evidence gates; they do not provide legal advice, endorse a vendor, or validate the benchmark. Relevant B2B contexts include a hospital or clinic evaluating equipment or services, a life-sciences organization sourcing research or production support, and a laboratory or manufacturer evaluating regulated supply. Confounders include patient enquiries, clinical education, trial recruitment, employment, academic research, investor interest, support requests, consumer wellness traffic, unapproved-use questions, and people without institutional purchasing roles.

Why CPC behaves this way

The USD 6.43 CPC is modeled, not universal. Broad medical terms compete with patient and consumer traffic. Product, indication, institution, profession, and location terms can be narrower but more commercially or clinically specific. Actual CPC varies with jurisdiction, channel, specialty, brand demand, policy restrictions, targeting method, device, search versus professional social, and whether the action is educational, clinical, research, or procurement-oriented. WordStream/LocaliQ offers public U.S. search context but is not a pure global B2B healthcare and life-sciences cohort (WordStream, 2026 Google Ads Benchmarks). The model uses assigned proxy roles rather than calling that source the SGT-18 row.

Why CPA and MQL diverge

Clinical and technical content attracts legitimate professionals who may not be buyers. A demo request may fail institution, use case, geography, approval path, privacy requirement, budget process, or product fit. A patient request must be handled outside a B2B procurement funnel. Multiple members of a committee can register for content, creating contact activity without multiple independent opportunities. First Page Sage reports industry and channel lead-to-MQL proxies and B2B landing-page conversion from proprietary agency cohorts. Medical-device, biotech, and pharmaceutical families are useful adjacent evidence, but their definitions do not create one universal SGT-18 qualification model (First Page Sage, Lead-to-MQL Benchmarks; First Page Sage, B2B Landing Page Conversion Rates).

Clinical-Research-Procurement Intent Separation Grid

Intent Evidence Correct path False-positive risk Patient/consumer Individual need or care question Patient-safe service path, not B2B acquisition Mistaken institutional lead Clinical information Professional role and information purpose Education or medical-information path Content activity overstated as buying intent Research Institution, protocol or program, requirement, timeline Research collaboration or sourcing review Student, publication, or general science interest Procurement Organization, use case, specification, authority, process B2B qualification review Vendor research without active purchase Vendor/partner Offering, relationship request, authority Separate supplier or partnership path Misclassified buyer demand For planning only, use 0.80 x USD 260 for a tightly separated institutional cohort, 1.00 x for base, and 1.20 x for mixed patient, research, and procurement traffic. The results are USD 208, USD 260, and USD 312, within the USD 205-315 band. These are illustrative factors.

Illustrative planning scenario

Assume a fictional mature cohort records USD 8,200 of attributable acquisition cost and 100 valid actions. 1 Lead-action CPA: USD 8,200 / 100 = USD 82. 2 Modeled MQL count: 100 x 31.7% = 31.7. 3 Unrounded modeled cost per MQL: USD 8,200 / 31.7 = USD 258.68. 4 Published point estimate: USD 260 after nearest-USD-5 rounding. The example is not medical advice, a patient forecast, regulatory decision, procurement award, product price, or customer outcome.

How to compare your data

Match currency, period, geography, channel, objective, action, and attribution window. Separate patient, clinical-information, research, procurement, vendor, support, and recruitment populations. Deduplicate by institution and initiative. Record organization type, role, use case, product family, jurisdiction, approval path, privacy or security requirement, account status, rejection reason, and qualification version. Allow regulated and committee review to mature. Do not use sensitive clinical details as a shortcut to commercial qualification. The minimum useful demand record is usually organizational: institution, professional role, approved communication path, business requirement, product or service scope, and evidence status. Access to patient or protected information is not proof of intent and may create separate governance obligations. Keep clinical safety, privacy, regulatory, and commercial-review fields distinct so one missing item does not silently become a score of zero.

How it was modeled

The CPC is imported from the frozen pricing-system registry. CPA, MQL rate, MQL cost, band, and confidence are SellersGPT modeled. The model uses a 70% normalized proxy plus a 30% channel baseline, caps raw rates at 24%-38%, calculates at full precision, and rounds cost per MQL to the nearest USD 5. Medium-High confidence reflects strong medical-device, biotech, pharmaceutical, and healthcare proxy families, offset by materially different provider, research, product, privacy, and purchasing contexts.

What it does not prove

This report does not provide medical, regulatory, privacy, legal, or procurement advice. It does not prove a universal average, qualified institution, approval, meeting, SQL, opportunity, revenue, CAC, or ROI, and does not publish a SellersGPT Qualified Lead price.

FAQ

Is a clinical-content registration an MQL? Not by itself. It needs role, institution, purpose, fit, and applicable engagement evidence. Should patient inquiries be included in B2B CPA? No, unless the campaign deliberately measures that separate outcome. Patient and procurement funnels must not be blended. Is USD 6.43 a healthcare lead price? No. It is the modeled advertising cost per paid click. Does regulatory classification prove buying intent? No. It helps define product and evidence context, not an institution's active demand. Why is cohort maturity important? Technical, privacy, clinical, committee, and procurement review may occur well after the first action.

Sources and methodology

• DEF-01: Average cost-per-click (Avg. CPC): Definition, Google Ads Help. Accessed 2026-08-25. Defines CPC only.

• DEF-03: Average CPA: Definition, Google Ads Help. Accessed 2026-08-25. Defines CPA; no healthcare qualification rule.

• QUAL-02: Build Person Scoring Models for Marketo Engage Programs, Adobe Experience League. Accessed 2026-08-25. Fit and behavior guidance; no benchmark.

• BENCH-03: Google Ads Benchmarks 2026, WordStream by LocaliQ. Accessed 2026-08-25. Search context; not direct SGT-18 data.

• BENCH-05: Lead-to-MQL Conversion Rate Benchmarks by Industry & Channel, First Page Sage. Accessed 2026-08-25. Adjacent proxy with cohort limits.

• BENCH-07: B2B Landing Page Conversion Rates: 2026 Report, First Page Sage. Accessed 2026-08-25. CTA conversion context only.

• GOV-01: North American Industry Classification System, U.S. Census Bureau. Accessed 2026-08-25. Taxonomy crosswalk only.

• IND-18-FDA: Overview of Device Regulation, U.S. Food and Drug Administration. Accessed 2026-08-25. U.S. device-class context; no acquisition benchmark.

• IND-18-HHS: Covered Entities and Business Associates, U.S. Department of Health and Human Services. Reviewed 2024-08-21. U.S. privacy-role context; not legal advice or lead-cost data.